subject area of
- Association Between Incretin-Based Drugs and the Risk of Acute Pancreatitis Academic Article
- Cardiovascular Outcomes Trials in Type 2 Diabetes: Where Do We Go From Here? Reflections From aDiabetes CareEditors’ Expert Forum Academic Article
- Cardiovascular events and all-cause mortality associated with sulphonylureas compared with other antihyperglycaemic drugs: A Bayesian meta-analysis of survival data Academic Article
- Dipeptidyl peptidase-4 inhibitors and risk of heart failure in type 2 diabetes: systematic review and meta-analysis of randomised and observational studies Academic Article
- Gastrointestinal Adverse Events of Dipeptidyl Peptidase 4 Inhibitors in Type 2 Diabetes: A Systematic Review and Network Meta-analysis Academic Article
- Incretin based drugs and the risk of pancreatic cancer: international multicentre cohort study Academic Article
- Incretin based treatments and mortality in patients with type 2 diabetes: systematic review and meta-analysis Academic Article
- Incretin treatment and risk of pancreatitis in patients with type 2 diabetes mellitus: systematic review and meta-analysis of randomised and non-randomised studies Academic Article
- Safety and efficacy of dipeptidyl peptidase-4 inhibitors vs sulfonylurea in metformin-based combination therapy for type 2 diabetes mellitus: Systematic review and meta-analysis Academic Article
- Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus Academic Article
- Secular trends in antihyperglycaemic medication prescriptions in older adults with diabetes and chronic kidney disease: 2004-2013 Academic Article